4-methylumbelliferyl-galactopyranoside has been researched along with alpha-Galactosidase A Deficiency in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, Y; Fukushige, T; Itoh, K; Jigami, Y; Kanekura, T; Kawashima, I; Kuroda, M; Ohashi, T; Ohno, K; Sakuraba, H; Sugawara, K; Suzuki, T; Tajima, Y; Togawa, T; Tsukimura, T | 1 |
| Donaldson, ML; Mayes, JS; Scheerer, JB; Sifers, RN | 1 |
2 other study(ies) available for 4-methylumbelliferyl-galactopyranoside and alpha-Galactosidase A Deficiency
| Article | Year |
|---|---|
Use of a modified alpha-N-acetylgalactosaminidase in the development of enzyme replacement therapy for Fabry disease.
Topics: alpha-N-Acetylgalactosaminidase; Amino Acid Substitution; Animals; Binding Sites; Catalysis; Cells, Cultured; CHO Cells; Cricetinae; Cricetulus; Culture Media, Conditioned; Disease Models, Animal; DNA, Complementary; Drug Stability; Enzyme Replacement Therapy; Fabry Disease; Fibroblasts; Fluorescent Dyes; Galactosides; Genetic Vectors; Humans; Hydrogen-Ion Concentration; Hymecromone; Immunohistochemistry; Kidney; Liver; Mice; Mice, Knockout; Models, Molecular; Molecular Weight; Myocardium; Recombinant Proteins; Retroviridae; Transfection; Trihexosylceramides | 2009 |
Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease.
Topics: Acetylgalactosamine; Adult; alpha-Galactosidase; alpha-N-Acetylgalactosaminidase; Cells, Cultured; Fabry Disease; Female; Fibroblasts; Galactosidases; Galactosides; Genetic Carrier Screening; Hexosaminidases; Humans; Hymecromone; Lysosomes; Male | 1981 |